Colorectal cancer is one of the most common diseases in China. Whether stage 11 patients should receive adjuvant chemotherapy was controversial. Here we summarize the latest advancement about clinical risk factors and biomarkers for the adjuvant chemotherapy of stage 11 colon cancer.